Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Harmony Biosciences Holdings (HRMY) EBIAT (2019 - 2025)

Historic EBIAT for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $50.9 million.

  • Harmony Biosciences Holdings' EBIAT rose 1035.3% to $50.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $185.7 million, marking a year-over-year increase of 5141.77%. This contributed to the annual value of $145.5 million for FY2024, which is 1291.39% up from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' EBIAT stood at $50.9 million, which was up 1035.3% from $39.8 million recorded in Q2 2025.
  • Over the past 5 years, Harmony Biosciences Holdings' EBIAT peaked at $87.9 million during Q3 2022, and registered a low of -$9.6 million during Q3 2021.
  • Over the past 5 years, Harmony Biosciences Holdings' median EBIAT value was $34.3 million (recorded in 2023), while the average stood at $33.0 million.
  • The largest annual percentage gain for Harmony Biosciences Holdings' EBIAT in the last 5 years was 5238518.52% (2021), contrasted with its biggest fall of 60392.88% (2021).
  • Harmony Biosciences Holdings' EBIAT (Quarter) stood at $22.7 million in 2021, then soared by 113.56% to $48.5 million in 2022, then crashed by 45.15% to $26.6 million in 2023, then skyrocketed by 85.95% to $49.5 million in 2024, then increased by 2.81% to $50.9 million in 2025.
  • Its EBIAT stands at $50.9 million for Q3 2025, versus $39.8 million for Q2 2025 and $45.6 million for Q1 2025.